# BIOTECHNOLOGY INNOVATION ORGANIZATION: SI Lobbying

> BIOTECHNOLOGY INNOVATION ORGANIZATION: $12.1M disclosed on 7 lobbying reports that name SI issues, Q1 2025 to Q3 2026. Every filing linked, from LDA.gov.

Source: https://tsio.si/money-map/biotechnology-innovation-organization/
Updated: 2026-11-19
Publisher: The SI Observatory (tsio.si), run by the SI community, built by Codeflex

1. [Home](https://tsio.si/)
2. [SI Money Map](https://tsio.si/money-map/)
3. BIOTECHNOLOGY INNOVATION ORGANIZATION

SI Money Map · Client

# BIOTECHNOLOGY INNOVATION ORGANIZATION and SI policy

**BIOTECHNOLOGY INNOVATION ORGANIZATION is the client on 7 federal lobbying reports that name SI issues, Q1 2025 to Q3 2026, disclosing $12.1M by the amount rule: $5.6M in 2025 and $6.5M in 2026 so far.** It filed 7 reports for itself. Rank 38 of 1,245 clients. Read from LDA.gov, Nov 17, 2026. Amounts are filing totals for all issues on each filing.

Updated **Nov 17, 2026** · Rank **38** · **7** SI filings

The filings

[Every company](https://tsio.si/money-map/#companies)

[Share on X](https://x.com/intent/post?text=BIOTECHNOLOGY+INNOVATION+ORGANIZATION%3A+%2412.1M+disclosed+on+7+lobbying+reports+that+name+SI+issues.+From+LDA.gov%2C+on+the+SI+Money+Map%3A&url=https%3A%2F%2Ftsio.si%2Fmoney-map%2Fbiotechnology-innovation-organization%2F)

- **Reported, all quarters**: $12.1M
- **SI filings**: 7
- **Quarters with filings**: 7
- **Lobbyist IDs on SI**: 15

Over time

## Quarter by quarter

Q1 2025 to Q3 2026. Q3 2026 reports were due Oct 20, 2026.

*Chart: BIOTECHNOLOGY INNOVATION ORGANIZATION: reported amount by quarter. By the amount rule: the in-house report when there is one, else the outside firms' reports.*

| Quarter | Filings | In-house | Outside firms | Counted |
|---|---|---|---|---|
| Q3 2026 | 1 | $2,560,000 | none | **$2,560,000** |
| Q2 2026 | 1 | $2,360,000 | none | **$2,360,000** |
| Q1 2026 | 1 | $1,620,000 | none | **$1,620,000** |
| Q4 2025 | 1 | $1,510,000 | none | **$1,510,000** |
| Q3 2025 | 1 | $1,350,000 | none | **$1,350,000** |
| Q2 2025 | 1 | $1,840,000 | none | **$1,840,000** |
| Q1 2025 | 1 | $890,000 | none | **$890,000** |

SI filings and amounts by quarter. Counted: the in-house amount when BIOTECHNOLOGY INNOVATION ORGANIZATION filed an SI report for itself that quarter, otherwise the outside firms' amounts. Subcontracts are never added.

The filings

## Every SI filing for BIOTECHNOLOGY INNOVATION ORGANIZATION

Each LD-2 report with at least one issue line that names SI, newest first, with the link to the filing on LDA.gov. "SI lines" shows how many of the filing's issue lines name SI.

| Quarter | Filed by | Amount | SI lines | Issue codes and bills | Source |
|---|---|---|---|---|---|
| Q3 2026Q3, posted Oct 20, 2026 | BIOTECHNOLOGY INNOVATION ORGANIZATIONIn-house | $2,560,000 | 3 of 9 | Copyright/Patent/Trademark, Health Issues, Medicare/MedicaidH.R. 10359, H.R. 10568, H.R. 10569, H.R. 10628, H.R. 1414, H.R. 1492, H.R. 1672, H.R. 3152 ... | [LDA.gov](https://lda.gov/filings/public/filing/2ad0b4ea-5138-4fa2-ab9a-ee1e91d083eb/print/) |
| Q2 2026Q2, posted Jul 20, 2026 | BIOTECHNOLOGY INNOVATION ORGANIZATIONIn-house | $2,360,000 | 2 of 9 | Copyright/Patent/Trademark, Health IssuesH.R. 1672, H.R. 3152, H.R. 3160, H.R. 3269, H.R. 3521, H.R. 5256, H.R. 5391, H.R. 6423 ... | [LDA.gov](https://lda.gov/filings/public/filing/502870c0-d272-474e-8980-b4e5519180f8/print/) |
| Q1 2026Q1, posted Apr 20, 2026 | BIOTECHNOLOGY INNOVATION ORGANIZATIONIn-house | $1,620,000 | 3 of 9 | Copyright/Patent/Trademark, Health Issues, Medicare/MedicaidH.R. 1262, H.R. 1492, H.R. 1672, H.R. 3152, H.R. 3160, H.R. 3269, H.R. 5391, H.R. 6166 ... | [LDA.gov](https://lda.gov/filings/public/filing/aa3a50d4-e002-4373-a5cf-812a7ace6757/print/) |
| Q4 2025Q4, posted Jan 20, 2026 | BIOTECHNOLOGY INNOVATION ORGANIZATIONIn-house | $1,510,000 | 3 of 9 | Copyright/Patent/Trademark, Health Issues, Medicare/MedicaidH.R. 1262, H.R. 1492, H.R. 1672, H.R. 3152, H.R. 3160, H.R. 5256, H.R. 6166, H.R. 6423 ... | [LDA.gov](https://lda.gov/filings/public/filing/cc3c3d81-dca7-45fa-9389-0790ef9b06a4/print/) |
| Q3 2025Q3, posted Oct 20, 2025 | BIOTECHNOLOGY INNOVATION ORGANIZATIONIn-house | $1,350,000 | 3 of 9 | Copyright/Patent/Trademark, Health Issues, Medicare/MedicaidH.R. 1, H.R. 1262, H.R. 1492, H.R. 1672, H.R. 3152, H.R. 3160, H.R. 3493, H.R. 3521 ... | [LDA.gov](https://lda.gov/filings/public/filing/572f615c-e68e-494e-a17e-e38148188ad2/print/) |
| Q2 2025Q2, posted Jul 21, 2025 | BIOTECHNOLOGY INNOVATION ORGANIZATIONIn-house | $1,840,000 | 3 of 15 | Copyright/Patent/Trademark, Health Issues, Medicare/MedicaidH.R. 1262, H.R. 1492, H.R. 1672, H.R. 3375, H.R. 3493, H.R. 3701, H.R. 946, S. 1587 ... | [LDA.gov](https://lda.gov/filings/public/filing/69891cd6-56c3-43bf-8c8e-d2c8a23daf47/print/) |
| Q1 2025Q1, posted Apr 21, 2025 | BIOTECHNOLOGY INNOVATION ORGANIZATIONIn-house | $890,000 | 3 of 15 | Copyright/Patent/Trademark, Health Issues, Medicare/MedicaidH.R. 1262, H.R. 1492, H.R. 1672, H.R. 946, S. 1095, S. 1096, S. 1097, S. 526 ... | [LDA.gov](https://lda.gov/filings/public/filing/88c831f3-1763-4962-a53c-4fa75c5904bf/print/) |

Amount: income reported by an outside firm, or expenses reported in-house, for all issues on the filing.

In their own words

## What the filings say

The SI issue lines, quoted as filed: newest first, repeats left out, long lines cut short. The words are the filers'; the filings are public records.

- **Names as filed**: BIOTECHNOLOGY INNOVATION ORGANIZATION
- **Issue codes**: Copyright/Patent/Trademark (7), Health Issues (7), Medicare/Medicaid (6)
- **Bills named**: H.R. 1672 (13), S. 527 (13), S. 1096 (12), S. 1097 (12), S. 1095 (10), S. 43 (10), H.R. 946 (9), S. 864 (9), H.R. 1492 (9), S. 1041 (9), S. 2276 (9), H.R. 6485 (9)

1. Q3 2026 "Antitrust Legislation ---Oversight Pharmacy Benefit Managers Artificial Intelligence (AI) ---Patentability of AI Assisted Inventions Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act Compulsory Licensing ---28 U.S.C. 1498 - Patent and copyright cases Data Privacy ..." Copyright/Patent/Trademark, filed by BIOTECHNOLOGY INNOVATION ORGANIZATION. [The filing](https://lda.gov/filings/public/filing/2ad0b4ea-5138-4fa2-ab9a-ee1e91d083eb/print/)
2. Q3 2026 "FY 2026 Appropriations for Agencies ---Administration for Strategic Preparedness and Response (ASPR) ---Centers for Disease Control and Prevention (CDC) ---Centers for Medicare and Medicaid (CMS) ---Food & Drug Administration (FDA) ---Health Resources and ..." Health Issues, filed by BIOTECHNOLOGY INNOVATION ORGANIZATION. [The filing](https://lda.gov/filings/public/filing/2ad0b4ea-5138-4fa2-ab9a-ee1e91d083eb/print/)
3. Q3 2026 "FY 2026 Appropriations for Specific Issues ---Alternative Funding Programs ---Antimicrobial Resistance (General) ---CMMI: GLOBE and GUARD Models ---Drug Pricing ---Pandemic Preparedness - R&D Funding for Medical Countermeasures ---Vaccines and Infectious ..." Medicare/Medicaid, filed by BIOTECHNOLOGY INNOVATION ORGANIZATION. [The filing](https://lda.gov/filings/public/filing/2ad0b4ea-5138-4fa2-ab9a-ee1e91d083eb/print/)
4. Q2 2026 "Antitrust Legislation ---Oversight Pharmacy Benefit Managers Artificial Intelligence (AI) Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act ---March-In Rights Compulsory Licensing ---28 U.S.C. 1498 - Patent and copyright cases Data Privacy ---H.R.8413: SECURE ..." Copyright/Patent/Trademark, filed by BIOTECHNOLOGY INNOVATION ORGANIZATION. [The filing](https://lda.gov/filings/public/filing/502870c0-d272-474e-8980-b4e5519180f8/print/)
5. Q1 2026 "Antitrust Legislation ---Oversight Pharmacy Benefit Managers Artificial Intelligence (AI) Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act Compulsory Licensing ---28 U.S.C. 1498 - Patent and copyright cases Data Privacy ---Data Privacy Working Group Draft ..." Copyright/Patent/Trademark, filed by BIOTECHNOLOGY INNOVATION ORGANIZATION. [The filing](https://lda.gov/filings/public/filing/aa3a50d4-e002-4373-a5cf-812a7ace6757/print/)
6. Q1 2026 "FY 2026 Appropriations for Agencies ---Administration for Strategic Preparedness and Response (ASPR) ---Biomedical Advanced Research and Development Authority (BARDA) ---Centers for Disease Control and Prevention ---Centers for Medicare and Medicaid (CMS) ..." Health Issues, filed by BIOTECHNOLOGY INNOVATION ORGANIZATION. [The filing](https://lda.gov/filings/public/filing/aa3a50d4-e002-4373-a5cf-812a7ace6757/print/)
7. Q4 2025 "Antitrust Legislation ---General ---Oversight Pharmacy Benefit Managers Artificial Intelligence (AI) Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act ---NIST RFI Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March in Rights ..." Copyright/Patent/Trademark, filed by BIOTECHNOLOGY INNOVATION ORGANIZATION. [The filing](https://lda.gov/filings/public/filing/cc3c3d81-dca7-45fa-9389-0790ef9b06a4/print/)
8. Q4 2025 "FY 2026 Appropriations for Agencies ---ASPR ---Centers for Disease Control and Prevention ---FDA ---Health Resources and Services Administration (HRSA) ---HHS Office of Infectious Disease and HIV/AIDS Policy ---National Institutes of Health FY 2026 ..." Health Issues, filed by BIOTECHNOLOGY INNOVATION ORGANIZATION. [The filing](https://lda.gov/filings/public/filing/cc3c3d81-dca7-45fa-9389-0790ef9b06a4/print/)

Embed

## Put this card on any page

A plain image that links back here, with its source printed on it. Free under CC BY 4.0. **Filings, not influence.** The SI Money Map shows what federal disclosure filings report: who paid for lobbying, which issues and bills the filings name, and what super PACs raised and spent. It does not show influence, intent or results, and it takes no side.

Copy the embed

```
<a href="https://tsio.si/money-map/biotechnology-innovation-organization/"><img src="https://tsio.si/money-map/biotechnology-innovation-organization/card.svg" width="480" height="240" alt="The SI Money Map: BIOTECHNOLOGY INNOVATION ORGANIZATION, $12.1M reported on SI lobbying filings"></a>
```

![SI Money Map card for BIOTECHNOLOGY INNOVATION ORGANIZATION](https://tsio.si/money-map/biotechnology-innovation-organization/card.svg)
